Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Biopharm Drug Dispos. 2011 Sep 22;32(8):471–481. doi: 10.1002/bdd.770

Figure 2.

Figure 2

Schematic diagram of the integrated bone homeostasis model, which is adapted from Lemaire et al. [15]. The model incorporates the action of denosumab and ibandronate and links the relevant biomarkers (sNTX, uNTX, uCTX) and a clinical endpoint (BMD) to physiological state variables. Details are provided under PD model in Methods.